- Acquisition adds GALE-401 (Anagrelide CR) to expand Galena's product pipeline.
- Phase 2 clinical trial expected to begin in mid-2014 with GALE-401 to treat Essential Thrombocythemia (ET), an orphan myeloproliferative disorder.
An SEC enforcement action uncovers the deep involvement and brazen misbehavior of biotech CEOs in an illegal stock promotion scheme.
Look for beaten-down stocks that are trading at discounts to the value of their assets. Finding absolute bottoms in stocks is not as important as you may think.
Cramer points to Gilead's pipeline for its problems.